| Tag | Content |
|---|
EnhancerAtlas ID | HS127-19210 |
Organism | Homo sapiens |
Tissue/cell | Macrophage |
Coordinate | chr20:32141890-32143940 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxa2 | MA0047.2 | chr20:32143004-32143016 | TGTTTACATTGG | + | 6.62 | | IRF1 | MA0050.2 | chr20:32142378-32142399 | CTTTTCTTTCCTTTTCCTTTT | + | 6.21 | | IRF9 | MA0653.1 | chr20:32142436-32142451 | AGTTTCGCTTTTGTT | - | 6.52 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_33625 | chr20:32139423-32144536 | H2171 | | SE_62132 | chr20:32139591-32165641 | Toledo | | SE_66994 | chr20:32139423-32144536 | H2171 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr20 | 32142835 | 32143155 | | chr20 | 32142161 | 32143892 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH20I033553 | chr20 | 32141222 | 32144277 |
|
Enhancer Sequence | TATTTTTGCA ACCTGATGCT TGAAATACCA TATAATATTA TTTTGTTCTT AAGTGACAGA 60
TGAAGAAACA TTCCAGGTTG CTGTTTGCAG AACTTCTGTG CAAGTAAGGA GTTATTACAA 120
TGAAAAGCAA ATTCACTATA AGCACCAGTG TTTATTTTTC TTACTTTTTT CTTTTTTTTT 180
TTTTTTTTCA GACAGTGTTG CTCTGTCACC CAAGCTGGAG TGCAGAGGCA TGATCTCAGC 240
TCACTGCAGC CTTCGCCTCC TGGGTTCAAG TGATTCTCCT GCCTCAGTCT CCTGAGTGGG 300
ATTACAGGCT TGTGCCACCT GGCCCAGCTA GGTTTTGTAT TTTTAGTAGA GACGGGGTTT 360
CACCATGTTG ACCAGGCTGT TCTCGAACTC CTGACCTCAA GTGATCTGCC CACCTCAGCC 420
TCCTAAATTG CTGGGGTTAC AGGGGTGAGC CACTGCGCCC GGCCTATTTT TCTTTTTTCT 480
TTTCTTTTCT TTTCTTTCCT TTTCCTTTTT CTTTTCTTTT TTTTTTTTTT TTTTTTTTTG 540
AGATGGAGTT TCGCTTTTGT TGTCCAGGTT GGAGTGCAGT GGAGTGATCT CAGCCTCCCA 600
AATTGCTGGG GTTACAGGTG TGAGCCACTG CGCCTGGCTG TTTTTCTTTT TTAACGTTGT 660
TTGAAAGTCT AGAATCATTT TTATGTGCTA GATGAGAGAT TTGATCTGAT AAATCAAACT 720
CAGATGTCTG CATCTCAAGT GTATTTGTAG AATTATTTTT CTGTTTTCTA TTAATTTAGA 780
TTGAATGTCA GAGTACCCAT TATAGGTATT AAAATGAATA TTACATAAGA AAAAATAACA 840
ACTTAAAAAT GTTCAGAATT GTTTAAATAA AAACTTTAGA CAGACATTTA GCAGAATTTA 900
GGTGAGCATT AAAGGATTCA GGCAGCATTC AAAACTGGAA GAAGTTCAGA GAGCTCTGCT 960
TTAGAAGCAG GCTTTTATAG GCTGAACGCT GTAGCAAAGT AAAGGAATTA CTTGATTGGC 1020
TGTAGCTAGG CACTTGCCTT ATTTGGATAT GATCCAGTGG AAAGTCCCTA GTTAGAGGTT 1080
TGTTTTTGAT TGGTTAAGCT TAAGTTTCAT TTTATGTTTA CATTGGGCTT CAGTTTGCTT 1140
ACTAGGCACT GGAGCCAGCT GTCTCAGCCT AATGGCTGCC CAATTTAAAA AAAAAAAAAC 1200
ATTAAAATGG CATGTAGTTG TCATCATCAG AGTAAGAAAC CAAAGAAGAG ACCGTCATGA 1260
ATGGGATCAT TAGATCATGG ACTGACACAC ATGTTCACTT AATACCCACA AGAGTGTCTT 1320
CACACTTTTT TGTCATGGAT GGGACTTGTT TTCTGTTTTT TGTTTTGTTT TGTTTTTGAT 1380
ACAGTAAAAT ACTTAGGAGT TCTTGCAACT TTCTATAAGT TGTTTACATT TTACTCCAAT 1440
TGCTTTATCA TTGTGTGTAT TTTGGAGGTA CAGTTTTTTT CCTGAACCAC TCTGAAAGTG 1500
GAAATATGCC CTTTTATCCC TAAATACTTA AATGCATATT TCCTGAAATC AAAGGCATTT 1560
TCTTACATAA CCACACATAA CCACAGTACA ATTATCAAAA TCAGAAAATG TAATAATGAT 1620
ACCATACTAT TAACCTGATT CACAGACTAT ATTCAGGTTT TATAAATTAT TTCAATAATG 1680
TCTTTTATAG CTCTTATACC TCAATCCAAT TCAGTCTGTC ATCACACACT GAATTTAACT 1740
GGCATGTCTC TTTCTTCCTT GCCTTTCCCC TTTCCTCTTT CCTTTTTTCT TCTTTCTTAG 1800
AGACAGGGTC TCATTCTGGT GCCCAGGCTA GGGTGCAGTG GTGCAATAAT GGCTCACTGC 1860
AGCCTTGACC TCCTGGACTC AGGCAATCCC CCAACCTCAG CCTCCTGAAT ACTTGGGAAT 1920
ATAGGCACAT GCCATTATGC CTGGCTAATT TTTTTTACTT TTTGTAGAGA TGGAGTCTCA 1980
CTACGTTGCT CCGGCTGGTC TCGAACTCCT TACCTTAAGT AAGCCACCTT CCTTGGCCTC 2040
CCAAAGTTTT 2050
|
